EUVIMEDEUVIMED entdecken
Crossref

Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity

Mohammad Reza Movahed iD, Spencer Bradshaw iD, Mehrtash Hashemzadeh

Artificial Organs · 2025

DOI: 10.1111/aor.15000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Mohammad Reza Movahed und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona Sarver Heart Center, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Obesity, Morbid, Overweight, Shock, Cardiogenic. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mortality of cardiogenic shock remains high, prompting increased use of mechanical circulatory support devices such as Impella. This study sought to characterize whether weight categories predict mortality in patients who received Impella devices.

Methods

We used data from the National Inpatient Sample (NIS) database from the years 2016 to 2020 and ICD‐10‐CM/PCS codes to evaluate the effect of weight categories on mortality in patients undergoing Impella implantation.

Results

A total of 86 810 patients underwent Impella device implantation, with an overall mortality of 29.85%. Mortality for normal weight was 30.4%, similar to cachexia (30.3%) and morbidly obese patients (31.1%). However, the overweight and obese categories had the lowest mortality (13.4% and 24.9%, p < 0.0001). Using multivariate analysis adjusting for comorbid conditions, overweight and obesity remained significantly associated with the lowest mortality (overweight: OR: 0.3, CI: 0.16–0.68, p = 0.003, Obese: OR: 0.8, CI: 0.71–0.91, p < 001) whereas morbid obesity was associated with the highest mortality (OR: 1.17, CI: 1.02–1.34, p = 0.02).

Conclusion

Using a large database, we found that overweight and obesity have a protective effect on mortality in patients undergoing Impella insertion. However, morbid obesity appears to have detrimental effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesObesity, MorbidOverweightShock, CardiogenicHumansMaleFemaleMiddle AgedAgedDatabases, FactualAdultRisk FactorsRetrospective StudiesUnited States

Stichwörter der Autor:innen

BMIImpellacardiogenic shockheart failuremechanical assist deviceobesityobesity paradoxsystolic heart failure

Autor:innen und Institutionen

  • University of Arizona Sarver Heart Center, Tucson, Arizona, USA.
  • University of Arizona College of Medicine, Phoenix, Arizona, USA.

ORCID-Profile: Mohammad Reza Movahed, Spencer Bradshaw

Zitieren

APA

Movahed, M. R., Bradshaw, S., & Hashemzadeh, M. (2025). Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity. Artificial Organs. https://doi.org/10.1111/aor.15000

Vancouver

Movahed MR, Bradshaw S, Hashemzadeh M. Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity. Artificial Organs. 2025. doi:10.1111/aor.15000

BibTeX
@article{Movahed2025,
  author = {Movahed, Mohammad Reza and Bradshaw, Spencer and Hashemzadeh, Mehrtash},
  title = {Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.15000}
}
Kostenlos starten →